Related Experiment Video
Updated: Jun 3, 2026

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
Malaria: severe, life-threatening
Susanne Helena Sheehy1, Brian John Angus
1University of Oxford, Oxford, UK.
Insights
This systematic review evaluates antimalarial treatments for severe falciparum malaria in non-pregnant individuals. It examines the effectiveness and safety of various interventions, including artemisinin derivatives and quinine, to guide clinical practice.
Area of Science:
- Infectious Diseases
- Tropical Medicine
- Pharmacology
Background:
- Severe malaria, particularly *Plasmodium falciparum*, poses a significant threat to young children, non-immune travelers, and residents of endemic areas.
- Cerebral malaria can lead to encephalopathy and coma, with a fatality rate of approximately 20% and potential for long-term neurological deficits in survivors.
- Severe malarial anemia is another critical complication, associated with a mortality rate exceeding 13%.
Purpose of the Study:
- To systematically review the efficacy and safety of antimalarial treatments and adjunctive therapies for complicated *falciparum* malaria in non-pregnant individuals.
- To answer key clinical questions regarding the effects of various interventions based on available scientific evidence.
Main Methods:
- Conducted a systematic literature review up to December 2009, searching major databases like Medline, Embase, and The Cochrane Library.
- Included data from 33 systematic reviews, randomized controlled trials (RCTs), and observational studies meeting inclusion criteria.
- Incorporated safety alerts from regulatory agencies such as the US FDA and UK MHRA.
Main Results:
- Identified and analyzed data from 33 relevant studies.
- Evaluated a range of antimalarial treatments and supportive care interventions.
Conclusions:
- The review synthesizes information on the effectiveness and safety of key interventions for severe malaria.
- Interventions examined include dexamethasone, blood transfusions (exchange and initial), quinine, and various artemisinin derivatives (intramuscular and intravenous artemether, artesunate, dihydroartemisinin).
- Provides evidence-based insights into managing complicated *falciparum* malaria.
Introduction:
Severe malaria mainly affects children under 5 years old, non-immune travellers, migrants to malarial areas, and people living in areas with unstable or seasonal malaria. Cerebral malaria, causing encephalopathy and coma, is fatal in around 20% of children and adults, and neurological sequelae may occur in some survivors. Severe malarial anaemia may have a mortality rate of over 13%.
Methods And Outcomes:
We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of antimalarial treatments and adjunctive treatment for complicated falciparum malaria in non-pregnant people? We searched: Medline, Embase, The Cochrane Library, and other important databases up to December 2009 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Results:
We found 33 systematic reviews, RCTs, or observational studies that met our inclusion criteria.
Conclusions:
In this systematic review we present information relating to the effectiveness and safety of the following interventions: dexamethasone, exchange blood transfusion, initial blood transfusion, intramuscular artemether, intravenous and intramuscular artesunate, intravenous and intramuscular dihydroartemisinin, quinine, and rectal/intravenous/intramuscular artemisinin and its derivatives.
More Related Videos
Related Concept Videos
Malaria
Bacterial Meningitis I: Introduction
Symbiosis
Rocky Mountain Spotted Fever
Cryptococcal Meningitis
Yellow Fever

